Haas B - Search Results

1

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.

Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K. Oddoux C, et al. Among authors: haas b. Nat Genet. 1996 Oct;14(2):188-90. doi: 10.1038/ng1096-188. Nat Genet. 1996. PMID: 8841192

2

BRCA-associated breast cancer: absence of a characteristic immunophenotype.

Robson M, Rajan P, Rosen PP, Gilewski T, Hirschaut Y, Pressman P, Haas B, Norton L, Offit K. Robson M, et al. Among authors: haas b. Cancer Res. 1998 May 1;58(9):1839-42. Cancer Res. 1998. PMID: 9581822

3

BRCA-associated breast cancer in young women.

Robson M, Gilewski T, Haas B, Levin D, Borgen P, Rajan P, Hirschaut Y, Pressman P, Rosen PP, Lesser ML, Norton L, Offit K. Robson M, et al. Among authors: haas b. J Clin Oncol. 1998 May;16(5):1642-9. doi: 10.1200/JCO.1998.16.5.1642. J Clin Oncol. 1998. PMID: 9586873

4

Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer.

Robson M, Dabney MK, Rosenthal G, Ludwig S, Seltzer MH, Gilewski T, Haas B, Osborne M, Norton L, Gilbert F, Offit K. Robson M, et al. Among authors: haas b. Genet Test. 1997;1(1):47-51. doi: 10.1089/gte.1997.1.47. Genet Test. 1997. PMID: 10464625

5

Fragile X syndrome in two siblings with major congenital malformations.

Giampietro PF, Haas BR, Lipper E, Gutman A, Zellers NJ, LaTrenta GS, Brooks SS, Matalon R, Kaul R, Ding XH, Brown WT. Giampietro PF, et al. Among authors: haas br. Am J Med Genet. 1996 May 17;63(2):396-400. doi: 10.1002/(SICI)1096-8628(19960517)63:2<396::AID-AJMG14>3.0.CO;2-F. Am J Med Genet. 1996. PMID: 8725793

6

The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma.

Ferrone CR, Haas B, Tang L, Coit DG, Fong Y, Brennan MF, Allen PJ. Ferrone CR, et al. Among authors: haas b. J Gastrointest Surg. 2006 Dec;10(10):1347-53. doi: 10.1016/j.gassur.2006.07.013. J Gastrointest Surg. 2006. PMID: 17175453

7

Determining Recommended Acceptable Intake Limits for N-Nitrosamine Impurities in Pharmaceuticals: Development and Application of the Carcinogenic Potency Categorization Approach (CPCA).

Kruhlak NL, Schmidt M, Froetschl R, Graber S, Haas B, Horne I, Horne S, King ST, Koval IA, Kumaran G, Langenkamp A, McGovern TJ, Peryea T, Sanh A, Ferreira AS, van Aerts L, Vespa A, Whomsley R. Kruhlak NL, et al. Among authors: haas b. Regul Toxicol Pharmacol. 2024 May 14:105640. doi: 10.1016/j.yrtph.2024.105640. Online ahead of print. Regul Toxicol Pharmacol. 2024. PMID: 38754805 Free article.

8

Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation.

Haas B, Hass MDS, Voltz A, Vogel M, Walther J, Biswas A, Hass D, Pfeifer A. Haas B, et al. Mol Metab. 2024 May 10;85:101956. doi: 10.1016/j.molmet.2024.101956. Online ahead of print. Mol Metab. 2024. PMID: 38735390 Free PMC article.

9

Greater mesophyll conductance and leaf photosynthesis in the field through modified cell wall porosity and thickness via AtCGR3 expression in tobacco.

Salesse-Smith CE, Lochocki EB, Doran L, Haas BE, Stutz SS, Long SP. Salesse-Smith CE, et al. Among authors: haas be. Plant Biotechnol J. 2024 Apr 30. doi: 10.1111/pbi.14364. Online ahead of print. Plant Biotechnol J. 2024. PMID: 38687118 Free article.

10

Taking High-Fidelity Simulation to the Next Level: Nursing in Nontraditional Environments.

Barnes GA, Haas BK. Barnes GA, et al. Among authors: haas bk. Nurs Educ Perspect. 2024 Apr 30. doi: 10.1097/01.NEP.0000000000001275. Online ahead of print. Nurs Educ Perspect. 2024. PMID: 38682875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

784 results

Search Page